ReviewJournal of the Pediatric Orthopaedic Society of North America2026
C-Type Natriuretic Peptide Derivatives: Orthopaedic Implications in Achondroplasia.
Review in Journal of the Pediatric Orthopaedic Society of North America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The recent development of C-type natriuretic peptide (CNP) analogs to increase growth velocity in achondroplasia is now being used alongside limb lengthening procedures. Animal studies have shown that CNP analogs may affect bone density and the speed of callus consolidation during fracture healing. Although achondroplasia is primarily associated with a defect in endochondral ossification, pharmaceutical treatments for the condition may also influence intramembranous ossification. The availability of these nonsurgical treatments warrants further investigation into their potential impact on surgical risks and outcomes. Data suggest that they may affect bone quality, healing, and anatomical parameters such as medullary canal area, which could influence treatment decisions and surgical planning. This review aims to synthesize current evidence on CNP analog pathways and their intersection with biological processes involved in the surgical management of children with achondroplasia. Key Concepts: (1)CNP-NPR-B activation boosts bone mineral density and improves fracture healing in mouse models.(2)CNP analogs are now used to treat achondroplasia, which could affect surgical limb lengthening procedures.(3)Clinicians should consider reporting bone healing features like callus quality and consolidation indices during bone healing to enhance our understanding of how pharmacotherapeutics may affect surgical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.